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ABSTRACT
Staphylococcus aureus is the most important type of bacteria causing infections in humans. There are
several potential factors for Staphylococcus aureus nasal careers in healthy adults, i.e. chronic sinusitis, the
long-term skin trauma, respiratory allergies, asthma, allergen injection therapy. Probiotics are life
microorganisms which have a positive effect on prevention or treatment of certain disease conditions when
consumed. Manipulation of intestinal flora with probiotics for the prevention and treatment of rhinitis allergy
should be developed. This study aims to determine the effect of supplementation probiotic Lactobacillus
casei Shirota strain against colonization Staphylococcus aureus nasal swab isolates from  patients with
allergic rhinitis.
This research was quasi-experimental case-control design with a control group pretest-postest design.
The study was conducted at the Microbiology and Research Laboratory School of Medicine Muhammadiyah
Yogyakarta University, on February-July 2011. Fourty two students school of medicine Muhammadiyah
Yogyakarta University, with the inclusion criteria suspect allergic rhinitis based on history. Volunteers who
have a history of allergic rhinitis were taken nasal swab to check the number of S.aureus bacteria. Volunters
consumed milk containing Lactobacillus casei strain Shirota daily for a month, then taken to be examined
nasal swab S.aureus bacteria numbers.
The results showed that the average number of bacteria nasal swab isolates before supplementation
about 92 CFU. After given the probiotic Lactobacillus casei Shirota strain during a month, the average
number of S.aureus about 27 CFU. It can be concluded that supplementation with Lactobacillus casei strain
Shirota probiotics can reduce Staphylococcus aureus colonization in patients with allergic rhinitis.
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INTRODUCTION
Staphylococcus aureus is a type of bacteria which is most important causing human
infection. Almost everyone will experience some type of infection S. aureus throughout his
life, from mild skin infections, food poisoning, to severe infections (Jawetz et al., 2005).
Research on Staphylococcus aureus community to be a little high due attention to Staphylo-
coccus aureus in the hospital setting. Based on previous studies, it is known that there are
several potential factors for career nasal Staphylococcus aureus in healthy adults. Such
factors include smoking, anatomical abnormalities of the nose, chronic sinusitis, diabetes
with insulin therapy, rheumatoid arthritis, hemodialysis, long-term skin trauma, respiratory
allergies, asthma, allergen injection therapy, other chronic diseases, contact with patients.
Allergic rhinitis is a chronic inflammatory disease of the nose. Allergic rhinitis become a
global health problem, affecting approximately 10 to 25% of the population. In Indonesia,
prevalence rhinitis allergic is not known for certain, but data from different hospitals showed
that allergic rhinitis has a frequency range from 10-26% (Sudarman, 2001). Allergic rhinitis
is not a fatal disease but the symptoms can affect a person’s health status and reduce the
ISSN 2413-0877 Volume 2 (2015) 124-128
The 3rd International Conference on Biological Science 2013 
(The 3rd ICBS-2013)
ISSN 2413-0877 © 2015 The Authors.
Published by KnowledgeE Publishing Services This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0)
Selection and Peer-review under responsibility of the 3rd ICBS-2013
Doi http://dx.doi.org/10.18502/kls.v2i1.130
125
quality of life of patients. Including lowering labor productivity, the effective time of work, and
school achievement (Baraniuk, 2000).
This disease is caused by inflammation of the nasal mucosa reaction mediated by im-
munoglobulin E (IgE), after exposure to allergens (type I hypersensitivity reaction Gell and
Combs). Disorders of the nose can be a symptom of itching of the nose that can extend to
the eyes and throat, sneezing, and nasal congestion (Bousquet et al., 2001).
Current research indicates that probiotics have a strong influence on the regulation of
primary immuno physiology in intestinal mucosal barrier (Rautava et al.,  2005). Probiotics
are live microorganisms, when consumed has a positive effect on the prevention or treat-
ment of a specific disease conditions. The potential use of probiotics alter the composition
of the intestinal flora in certain high-risk groups, such as premature babies, patients with
diarrhea, children treated antibiotics, patients with viral gastroenteritis and some atopic dis-
eases are not only potential applications but also due to the fact this agent interaction mecha-
nisms of probiotics with intestinal tissue (Saavendra, 2001).
Lactobacillus is a probiotic that is able to perform fermentation to break down food
substances that are not digested by the intestine to form lactic acid, hydrogen peroxide, and
other products that will not inhibit the beneficial bacteria (pathogens) and fungi. Lactobacil-
lus produce B vitamins (niacin, pyridoxine, and folic acid) and lactase enzyme which func-
tions to break down lactose into sugars short chain so it will be easier to digest (Anonim,
2009).
Lactobacillus and Bifidobacterium bacteria which is resistant to gastric acid and bile, is
able to adhere the walls of the gastrointestinal tract that protect the gastrointestinal mucosa,
and potentially capable of producing substances as antimicrobial, competing with patho-
genic microbes in nutrition and to increase the immune system response phagocytic cells
(Orrhage et al., 2000). As more and more evidence of the benefits of manipulation gut flora
with probiotics for the prevention and treatment of atopic disease, the benefits should be
developed on diseases of allergic rhinitis.
MATERIALS AND METHODS
Materials used for the examination of S. aureus bacteria numbers are: supplementation
milk contain L.casei strain Shirota, blood agar media, Manithol Salt Agar media, Gram staining,
sterile cotton sticks, petridish, test tubes, ose, bunsen flame, autoclave, measuring pipette,
tweezers. The data collected in this study were 42 students of school medicine Muhammadiyah
Yogyakarta University, who have a history of allergic rhinitis asked to fill out questionnaires.
From questionnaire, data qualified allergic rhinitis/atopy, nasal swabs were taken using sterile
cotton stick to be examined number of S. aureus bacteria. Furthermore, volunteers
supplemente milk containing L.casei strain Shirota for a month, then take a nasal swab for
S. aureus bacteria examined. Identification S.aureus bacteria using streak plate method.
Nasal swabs from volunters inoculate on blood agar, then incubated at 37 ° C, for 24 hours.
Colonies that grow to be identified using Gram staining. Colonies that have microscopic
characteristics cocci, Gram positive, clusters, calculated the amount then tested MSA in the
media by Manithol Salt Agar and incubated at 37 ° C, for 24 hours. MSA test is positive if the




The subject of this research are 42 students of school medicine, Muhammadiyah
Yogyakarta University. Selection of subjects based on history checks to make sure the sub-
jects suspect from allergic rhinitis. After the examination the total number of S. aureus bacte-
ria before and after the supplemented probiotic Lactobacillus casei strain Shirota for a month.
The results of the total number of bacteria can be seen in Figure 1. Of the 42 samples exam-
ined, nearly 100% of total number of bacteria decreased S. aureus nasal isolates.
Figure 1. The results bacteria numbers of S. aureus nasal isolates before and after suplementation
of the Lactobacillus casei strain Shirota for a month in patients with allergic rhinitis
The average bacteria number of S. aureus nasal isolates from allergic rhinitis suspect
before supplementation is 92 CFU. After suplementation of the Lactobacillus casei strain
Shirota for one month, the average number of bacteria is 27 CFU. The statistical analysis
paired t-test results obtained p <0.05. Top of Form
This study demonstrates that supplementation of Lactobacillus casei strain Shirota for
a month can reduce the bacteria number of S. aureus nasal isolates from allergic rhinitis
suspect. Giving probiotics in allergy prevention is homoestasis biological systems improve-
ment efforts aimed at patient immunomodulating the immune response by balancing Th1
and Th2 immune responses.
Probiotics are normal flora of the gastrointestinal tract that can control the balance of
intestinal microflora and the physiological effects that benefit the health of the host. Probiotics
also have the ability as a strong activator of the innate immune system because it has a
specific molecule on the cell wall, known as pathogen-associated molecular patterns (PAMPs).
Specific molecules (PAMPs) recognized by specific receptors (specific pattern recognition
receptors, PRRS). PAMPs existing one on probiotics is lipoteichoic acid (LTA). LTA, a bio-
logically active molecule, is a characteristic of Gram positive bacteria and has a biological
impact (induction of cytokine production) similar to LPS (Järveläinen & Miettinen, 2001;
Miettinen et al., 2001).
Biologically active molecules probiotics peptidoglycan and teichoic acid in the form of a
pathogen-associated molecular patterns (PAMPs) are recognized PRRS (pattern recogni-
tion receptors) in the case of TLR2 and TLR4. TLR2 and TLR4  induce transcription of sev-
eral proinflammatory cytokines in response to stimulation by probiotics, which help bridge
the innate immune system to the adaptive system by inducing a variety of effector molecules
and co-stimulators (Saito, 2004). Digestive tract as part separator inner protective of a wide
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range of antigens, derived from food and microorganisms from outside the body (Sanderson
& Walker, 1993). The gastrointestinal tract is an early defense for disposal antigen, elimina-
tion of foreign substances that enter through the gastrointestinal mucosa and regulate reac-
tions between antigens and specific immune responses (Brandtzaeg, 1995). Intestinal
microflora and probiotics may influence the host immune system through its effects on muco-
sal barrier and immune system maturation. Primary effector known as the innate imune sys-
tem, which is a non-specific defense system mediated by monocytes, macrophages, and
dendritic cells. Innate imune system contribute regulate the function of antigen-specific adap-
tive immune system, such as the balance of the immune response profile associated cytokine
or chemokine receptor. Lactobacillus GG has the ability to improve intestinal mucosal
immunity are particularly increasing the number of IgA-producing cells and other immuno-
globulin-producing cells, stimulates the local release of interferon which facilitates antigen
transport and increase the uptake of antigen by Peyer’s patches (Gorbach. 2000).
CONCLUSION
The conclusion of this study is supplementation of probiotic Lactobacillus casei strain
Shirota is able to reduce Staphylococcus aureus colonization in patients with allergic rhinitis.
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